Publicaciones en colaboración con investigadoras/es de Karolinska University Hospital (12)

2024

  1. The ECHO recommendations for dealing with vinblastine shortage affecting standard treatment of systemic Langerhans cell histiocytosis

    Pediatric Blood and Cancer

2021

  1. Additive Prognostic Impact of Gastrointestinal Involvement in Severe Multisystem Langerhans Cell Histiocytosis

    Journal of Pediatrics, Vol. 237, pp. 65-70.e3

2020

  1. Neuroinflammatory Disease as an Isolated Manifestation of Hemophagocytic Lymphohistiocytosis

    Journal of Clinical Immunology, Vol. 40, Núm. 6, pp. 901-916

  2. Stem cell transplantation for children with hemophagocytic lymphohistiocytosis: Results from the HLH-2004 study

    Blood Advances, Vol. 4, Núm. 15, pp. 3754-3766

2018

  1. Recommendations for the Use of Etoposide-Based Therapy and Bone Marrow Transplantation for the Treatment of HLH: Consensus Statements by the HLH Steering Committee of the Histiocyte Society

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 6, Núm. 5, pp. 1508-1517

2017

  1. Confirmed efficacy of etoposide and dexamethasone in HLH treatment: Long-Term results of the cooperative HLH-2004 study

    Blood, Vol. 130, Núm. 25, pp. 2728-2738

  2. Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome

    Journal of Pediatrics, Vol. 189, pp. 72-78.e3

2016

  1. Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis

    RMD Open, Vol. 2, Núm. 1

2015

  1. Lack of bone lesions at diagnosis is associated with inferior outcome in multisystem langerhans cell histiocytosis of childhood

    British Journal of Haematology, Vol. 169, Núm. 2, pp. 241-248

2014

  1. Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis

    Arthritis and Rheumatology, Vol. 66, Núm. 10, pp. 2871-2880

2013

  1. Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis

    Blood, Vol. 121, Núm. 25, pp. 5006-5014

2007

  1. Simultaneous manifestation of fulminant infectious mononucleosis with haemophagocytic syndrome and B-cell lymphoma in X-linked lymphoproliferative disease

    European Journal of Pediatrics, Vol. 166, Núm. 6, pp. 589-593